2.50
Hdl Handle:
http://hdl.handle.net/10541/80151
Title:
Pituitary tumour therapy: using the biology.
Authors:
Davis, Julian R E; Trainer, Peter J
Abstract:
Pituitary tumours are benign but cause significant problems, both because of their compressive effects on brain structures and also because of the syndromes of hormone excess or deficiency that they can cause. Endocrine therapy has become increasingly successful, with the development of dopamine agonists and somatostatin analogues. Recently growth hormone receptor antagonists have been developed by modification of the GH molecule. It is likely that further advances based on our understanding of the biology will dramatically improve the treatment of these tumours.
Affiliation:
Department of Endocrinology, Manchester Royal Infirmary &Christie Hospital, Manchester, UK.
Citation:
Pituitary tumour therapy: using the biology. 2002, 14 (12):1p following 978 J. Neuroendocrinol.
Journal:
Journal of Neuroendocrinology
Issue Date:
Dec-2002
URI:
http://hdl.handle.net/10541/80151
PubMed ID:
12521030
Type:
Article
Language:
en
ISSN:
0953-8194
Appears in Collections:
All Christie Publications

Full metadata record

DC FieldValue Language
dc.contributor.authorDavis, Julian R E-
dc.contributor.authorTrainer, Peter J-
dc.date.accessioned2009-09-07T16:25:12Z-
dc.date.available2009-09-07T16:25:12Z-
dc.date.issued2002-12-
dc.identifier.citationPituitary tumour therapy: using the biology. 2002, 14 (12):1p following 978 J. Neuroendocrinol.en
dc.identifier.issn0953-8194-
dc.identifier.pmid12521030-
dc.identifier.urihttp://hdl.handle.net/10541/80151-
dc.description.abstractPituitary tumours are benign but cause significant problems, both because of their compressive effects on brain structures and also because of the syndromes of hormone excess or deficiency that they can cause. Endocrine therapy has become increasingly successful, with the development of dopamine agonists and somatostatin analogues. Recently growth hormone receptor antagonists have been developed by modification of the GH molecule. It is likely that further advances based on our understanding of the biology will dramatically improve the treatment of these tumours.en
dc.language.isoenen
dc.subjectPituitary Canceren
dc.subject.meshAntineoplastic Agents, Hormonal-
dc.subject.meshGene Therapy-
dc.subject.meshHumans-
dc.subject.meshPituitary Neoplasms-
dc.titlePituitary tumour therapy: using the biology.en
dc.typeArticleen
dc.contributor.departmentDepartment of Endocrinology, Manchester Royal Infirmary &Christie Hospital, Manchester, UK.en
dc.identifier.journalJournal of Neuroendocrinologyen

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.